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 The main objective of this PhD thesis is to identify genetic susceptibility variants that 
contribute to the risk of essential hypersomnia (EHS) in Japanese population. EHS is a 
sleep disorder characterized by excessive daytime sleepiness (EDS), can be divided into two broad 
classes based on the presence or absence of the Human Leukocyte Antigen (HLA)-DQB1*06:02 
allele. This PhD candidate has focused on HLA-DQB1*06:02 negative EHS in which previous 
reports showed that this group of patients is pathophysiologically different from that of narcolepsy 
with cataplexy (another similar sleep disorder defined of excessive daytime sleepiness). A 
wide-range of experiments and analysis were performed in the search of genetic susceptibility 
variants for HLA-DQB1*06:02 negative EHS and the results are as follows: 
 
1. 3 SNPs that each represented a unique locus, rs16826005 (P = 1.02E-07; NCKAP5), rs11854769 
(P = 6.69E-07; SPRED1), and rs10988217 (P = 3.43E-06; CRAT) were associated with an 
increased risk of EHS in this Japanese population.  
 
2. rs10988217 in CRAT gene is associated with both HLA-DQB1*06:02 negative EHS and 
narcolepsy with cataplexy in both Japanese and Caucasian populations. In addition, eQTL 
analysis showed that risk allele of rs10988217 increased the expression of CRAT. Regulatory 
SNP in CRAT gene, together with previously identified CPT1B as susceptibility gene for 
narcolepsy through the long-chain fatty acid β-oxidation pathway contribute to the risk of 
having HLA-DQB1*06:02 negative EHS. 
 
3. MBP (P = 2.74E-06) and QKI (P = 2.22E-05) can act as potential markers to differentiate EHS 
from narcolepsy with cataplexy and the follow-up study of MBP level in the cerebrospinal fluid 
(CSF) showed EHS had a significant elevated level of CSF MBP(P = 2.50E-02) compared with 
those of narcolepsy with cataplexy. These results suggest that demyelination might occur in EHS 
patients. 
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4. Pathway analysis of the EHS identified the glutamate metabolism to be significant (P = 
1.70E-03) with the risk of having HLA-DQB1*06:02 negative EHS. High-performance liquid 
chromatography (HPLC) analysis on the HLA-DQB1*06:02 negative EHS CSF samples 
revealed that gamma-aminobutyric acid (GABA) is elevated compared to narcolepsy with 
cataplexy while glutamate and glutamine showed no associations. This result is parallel with the 
severity of EDS in narcolepsy with cataplexy    
 
The results above improve the understanding of genetic variations’ contribution to the 
pathogenesis for EHS. EHS is a relatively newly defined disease; a lot of studies remain to be 
done to fully understand the underlying mechanism which leads to the disease. These studies 
provided a comprehensive analysis from the identification of novel genetics factors to some 
preliminary functional study of the genetic variants identified, the results have been published in 
PeerJ journal and we think that it is sufficient for the PhD candidate to obtain a PhD degree.   
